In an email addressed to 140,000 Oracle employees, the CTO and president of the American software giant reveals his involvement in fighting the virus.
On the occasion of an internal message sent Tuesday March 31 to 140,000 Oracle employees, Larry Ellison, CTO and co-founder of the American software giant, and Safra Catz, CEO of the publisher, detail the strategy put in place for support scientists in the fight against Covid-19. Oracle’s engineering teams have deployed the group’s cloud-based applications to document coronavirus cases and associated treatments. Objective: to pool medical knowledge to enable physicians to target their prescriptions, dosages and dosages more effectively. “The first cloud systems we implemented manage clinical trials,” say Larry Ellison and Safra Catz. “To date, Oracle Cloud is used for clinical trials to test the efficacy and safety of seven different drugs and vaccines against Covid-19. These seven trials cover 17 countries and 250 institutional sites.” This email was forwarded to the JDN by a source inside the Redwood Shores group.
In their message, Larry Ellison and Safra Catz specify that on the occasion of this project, Oracle has developed a brand new cloud system, called Clinical One. A technology that is now available to healthcare players to manage their clinical trials.
Forbes has published an article on the subject which provides some additional information. He specifies in particular that the research applications on Covid-19 deployed on the Oracle cloud have been developed in collaboration with the Food and Drug Administration, the National Institutes of Health and other American federal organizations. According to Forbes, doctors will soon be able to register each treated Covid-19 case in the underlying database through the Oracle site. The system will then send emails to physicians or patients, requesting symptom status reports.